Anti-factor IIa (FIIa) heparin assay for patients on direct factor Xa (FXa) inhibitors.
Morgan StuartLinda JohnsonSarah HaniganSteven W PipeShih-Hon LiPublished in: Journal of thrombosis and haemostasis : JTH (2020)
The BIOPHEN ANTI-IIa assay is suitable for patients transitioning off apixaban or rivaroxaban.